טוען...
Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis
Background and objectives: Isolated case reports have shown a beneficial effect of rituximab on pediatric patients with primary FSGS, but there is no information about rituximab treatment of FSGS in adults. Design, setting, participants, & measurements: All patients who had biopsy-proven FSGS an...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Nephrology
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2723972/ https://ncbi.nlm.nih.gov/pubmed/19578004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.00570109 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|